Early Access — free while we kick the tires
EdgarHawk

Erck Stanley C

Director

Director
1 filing analyzed · 1 company · Latest 2025-08-13

Companies

Company Buys Sells Direction
MAXCYTE, INC. MXCT 1 0 Net buying

Activity

August 2025
2025-08-13 MAXCYTE, INC. MXCT
high
Buy
100,000 shares
$137,220
Significance 6/10

Director Erck Stanley C bought 100,000 shares of MXCT at $1.37 on 2025-08-13; 4 insiders bought within 14 days as stock down -72.9% from 52-week high.

Director Erck Stanley C purchased 100,000 shares at $1.37, increasing holdings by 33.5% to 398,328 shares. This transaction is part of a cluster pattern: 4 other insiders also bought within the past 14 days, suggesting coordinated insider accumulation despite challenging company fundamentals. MXCT is currently unprofitable with net income of $-12,357,000.00 over its most recent full fiscal year, annual revenue decline of -6.4%, and a stock price that has fallen -72.9% from its 52-week high of $5.10. The concentration of director-level buying during a period of severe price weakness and negative earnings warrants evaluation of whether these purchases reflect underlying operational recovery signals or represent a contrarian stance during distressed valuation conditions.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access